K-ras cancer gene mutations in lung tumors from female Swiss (CD-1) mice exposed transplacentally to 3'-azido-3'-deoxythymidine.
K-ras cancer gene mutations in lung tumors from female Swiss (CD-1) mice exposed transplacentally to 3'-azido-3'-deoxythymidine.
复制标题
经胎盘暴露于 3-叠氮基-3-脱氧胸苷的雌性瑞士 (CD-1) 小鼠肺部肿瘤中的 K-ras 癌症基因突变。
DOI:
10.1002/em.20420
复制
发表时间:
2008
影响因子:
2.8
通讯作者:
Sills,RobertC
中科院分区:
文献类型:
--
作者:
Koujitani,Takatoshi;Ton,Tai-VuT;Lahousse,StephanieA;Hong,Hue-HuaL;Wakamatsu,Nobuko;Sills,RobertC
A transplacental carcinogenicity study was conducted by exposing pregnant Swiss (CD‐1) mice to 0, 50, 100, 200, or 300 mg 3′‐azido‐3′‐deoxythymidine (AZT)/kg body weight (BW) daily for the duration of gestation (18–19 days) [National Toxicology Program,2006]. The incidence of alveolar/bronchiolar adenomas and carcinomas in the 200 and 300 mg/kg groups was significantly higher (P= 0.027 and 0.007, respectively) in male offspring, but not in females (P= 0.338 and 0.315, respectively). The purpose of the present study was to evaluate K‐rasmutation status in lung tumors from the female offspring in AZT exposed groups and to determine whether at the molecular level there were signature K‐rasmutations in lung tumors that were different from spontaneous tumors. K‐rasmutation was detected by cycle sequencing of polymerase chain reaction (PCR)‐amplified DNA, isolated from formalin‐fixed, paraffin‐embedded lung tumors. K‐rasmutations were detected in 17 of 28 (61%) lung tumors from the female offspring in AZT exposed groups. No K‐rasmutations were detected in the 8 tumors examined from the female control group. The predominant mutations were Codon 12 G→T transversions in the 50, 100, and 300 mg/kg groups, and Codon 12 G→C transversions in the 200 and 300 mg/kg groups. K‐rasCodon 12 G→T transversions (TGT mutations) may be induced by oxidative DNA damage and 8‐oxoguanine (8‐oxoG), while K‐rasCodon 12 G→C transversions (CGT mutations) may be due to further oxidative lesions of guanine and 8‐oxoG. Environ. Mol. Mutagen., 2008. Published 2008 Wiley‐Liss, Inc.